Since their development and widespread adoption in the late 1980s, proton pump inhibitors (PPI) have transformed the field of gastroenterology. Their high efficacy and favorable safety profiles have ...
Proton pump inhibitors (PPIs) do not appear to worsen kidney function compared with the histamine 2 receptor blocker ranitidine based on two measures, a large cohort study from Spain finds. In fact, ...
Use of PPIs or antibiotics was linked with worse overall survival in patients with renal cell carcinoma treated with immune checkpoint inhibitors. Specific concomitant medications are linked with ...
People who experience any of the symptoms while taking the medication are urged by the NHS to see a doctor ...
Accelerating phase 2 clinical development with real-world data (RWD): An external control arm (ECA) pilot in HER2-positive (HER2+) metastatic breast cancer (mBC). This is an ASCO Meeting Abstract from ...
In a recent study published in Neurology, researchers determine whether the current and cumulative use of prescription proton pump inhibitors (PPIs) increases the risk of incident dementia. Study: ...
Impact of gut microbiota (GM) and antibiotic (ATB) use on immunotherapy efficacy in patients with lung cancer (LC): Preliminary results from a prospective trial. This is an ASCO Meeting Abstract from ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results